Examining how some cancer cells cheat treatment-induced cell death

by St. Jude Children's Research HospitalGraphic abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.07.025Scientists at St. Jude Children's Research Hospital have identified

Updated on: January 30,2024

Examining how some cancer cells cheat treatment-induced cell death

by St. Jude Children's Research HospitalGraphic abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.07.025Scientists at St. Jude Children's Research Hospital have identified

Updated on:January 30,2024

Researcher reach milestone in the treatment of anemia in chronic lymphocytic leukemia

by Leipzig UniversityCredit: Pixabay/CC0 Public DomainIn people with myelodysplastic neoplasms (MDS), a usually benign form of chronic lymphocytic leukemia, the body produces too few functional b

Updated on: February 03,2024

Researcher reach milestone in the treatment of anemia in chronic lymphocytic leukemia

by Leipzig UniversityCredit: Pixabay/CC0 Public DomainIn people with myelodysplastic neoplasms (MDS), a usually benign form of chronic lymphocytic leukemia, the body produces too few functional b

Updated on:February 03,2024

New study challenges belief that opioids are effective at treating cancer pain

by Annie Slinn,University of WarwickEffect of geographic ancestry on CYP2D6 genotype. CYP2D6 indicates cytochrome P450 2D6. Adapted from information in Table1 of Gaedigk etal., 2017.

Updated on: December 30,2023

New study challenges belief that opioids are effective at treating cancer pain

by Annie Slinn,University of WarwickEffect of geographic ancestry on CYP2D6 genotype. CYP2D6 indicates cytochrome P450 2D6. Adapted from information in Table1 of Gaedigk etal., 2017.

Updated on:December 30,2023

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Updated on: January 11,2024

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Updated on:January 11,2024

Preventive mastectomy less common for black women with breast cancer

by Dennis ThompsonBlack women with cancer in one breast are less likely than white women to have the healthy breast removed as well, a new study has found.Women with cancer affecting one breast often

Updated on: April 28,2024

Preventive mastectomy less common for black women with breast cancer

by Dennis ThompsonBlack women with cancer in one breast are less likely than white women to have the healthy breast removed as well, a new study has found.Women with cancer affecting one breast often

Updated on:April 28,2024

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on: May 20,2024

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on:May 20,2024

After testicular cancer is cured, remain alert in the future

by University of Rochester Medical CenterBecause testicular cancer has a 95 percent cure rate, it is easier for men to move on and forget about it. But new research in theJournal of Clinica

Updated on: March 01,2024

After testicular cancer is cured, remain alert in the future

by University of Rochester Medical CenterBecause testicular cancer has a 95 percent cure rate, it is easier for men to move on and forget about it. But new research in theJournal of Clinica

Updated on:March 01,2024

Team identifies key driver of cancer cell death pathway that activates immune cells

by University of Illinois at Urbana-ChampaignThe research team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate st

Updated on: February 23,2024

Team identifies key driver of cancer cell death pathway that activates immune cells

by University of Illinois at Urbana-ChampaignThe research team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate st

Updated on:February 23,2024

Cancers in adults under 50 are on the rise globally

byBrigham and Women's HospitalCredit: Unsplash/CC0 Public DomainOver recent decades, more and more adults under the age of 50 are developing cancer. A study conducted by researchers from Bri

Updated on: January 02,2024

Cancers in adults under 50 are on the rise globally

byBrigham and Women's HospitalCredit: Unsplash/CC0 Public DomainOver recent decades, more and more adults under the age of 50 are developing cancer. A study conducted by researchers from Bri

Updated on:January 02,2024

AAFP still recommends CRC screening from age 50 to 75

(HealthDay)—In accordance with the U.S. Preventive Services Task Force (USPSTF), the American Academy of Family Physicians (AAFP) does not intend to change its recommendations for colorectal cancer sc

Updated on: March 27,2024

AAFP still recommends CRC screening from age 50 to 75

(HealthDay)—In accordance with the U.S. Preventive Services Task Force (USPSTF), the American Academy of Family Physicians (AAFP) does not intend to change its recommendations for colorectal cancer sc

Updated on:March 27,2024

A barrier that keeps cancer at bay

by Ecole Polytechnique Federale de LausanneLoss of a barrier to tumor formation: On the left, a protective barrier of activin B expression (red color) is present in normal pancreatic islets. On t

Updated on: March 27,2024

A barrier that keeps cancer at bay

by Ecole Polytechnique Federale de LausanneLoss of a barrier to tumor formation: On the left, a protective barrier of activin B expression (red color) is present in normal pancreatic islets. On t

Updated on:March 27,2024

Area surrounding a tumor impacts how breast cancer cells grow

by Amanda Gibbs,Oregon Health & Science University“Cancer is acomplex mixture of cancer cells, normal blood cells, tissue and immune cells. Tumor cells themselves alter the microenviro

Updated on: April 07,2024

Area surrounding a tumor impacts how breast cancer cells grow

by Amanda Gibbs,Oregon Health & Science University“Cancer is acomplex mixture of cancer cells, normal blood cells, tissue and immune cells. Tumor cells themselves alter the microenviro

Updated on:April 07,2024